Arginase II inhibitory activity of flavonoid compounds from Scutellaria indica

Arch Pharm Res. 2013 Aug;36(8):922-6. doi: 10.1007/s12272-013-0125-3. Epub 2013 Apr 20.

Abstract

Arginase II has recently reported as a novel therapeutic target for the treatment of cardiovascular diseases such as atherosclerosis. In the course of screening plants used in natural medicines as arginase II inhibitory activity, a methanol extract of Scutellaria indica showed significant inhibitory effect. Further fractionation and repeated column chromatography led to the isolation of a new flavan-type (1), and seven known compounds (2-8). The chemical structures of isolated compounds were elucidated based on extensive 1D and 2D NMR spectroscopic data. The isolates 1-8 were investigated in vitro for their arginase II inhibitory activity using enzyme solution prepared from kidney of anesthetized C57BL/6 mice. Compounds 3 and 5 significantly inhibited arginase II activity with IC₅₀ values of 25.1 and 11.6 μM, respectively, whereas the other compounds were apparently inactive.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginase / antagonists & inhibitors*
  • Arginase / metabolism*
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / isolation & purification
  • Enzyme Inhibitors / pharmacology
  • Flavonoids / chemistry*
  • Flavonoids / isolation & purification
  • Flavonoids / pharmacology*
  • Mice
  • Mice, Inbred C57BL
  • Plant Components, Aerial
  • Plant Extracts / chemistry*
  • Plant Extracts / isolation & purification
  • Plant Extracts / pharmacology*
  • Scutellaria / enzymology*

Substances

  • Enzyme Inhibitors
  • Flavonoids
  • Plant Extracts
  • Arg2 protein, mouse
  • Arginase